Hawkeye’s TEMPLAR Trial Approved in Denmark in Partnership with Vejle Hospital

Announcement
Written By Inform Solutions

Hawkeye’s TEMPLAR trial approved in Denmark for 3,000 patient prospective clinical trial in partnership’s with Vejle Hospital.

Inform Solutions https://inform.solutions/
Previous

ASCO Daily News: Lung Cancer Screening Remains Poor. Here’s How to Increase Rates and Save Lives
Next

Hawkeye expands TEMPLAR Clinical Trial Recruitment to Marmara University, Istanbul, Turkey